A A STUDY ON KNOWLEDGE, ATTITUDE, AND PRACTICE OF PHARMACOVIGILANCE TOWARD ADR REPORTING AMONG JUNIOR RESIDENT, SENIOR RESIDENT, AND CONSULTANT DOCTORS IN TERTIARY CARE SETTING OF TEACHING MEDICAL INSTITUTION

NATH SOM; SHARMA DEEPAK; NATH MANJUSHA

doi:10.22159/ajpcr.2024v17i8.51334

Authors

NATH SOM Department of Community Medicine, DSLP ASMC Pratapgarh, Uttar Pradesh, India https://orcid.org/0000-0002-1172-8326
SHARMA DEEPAK Department of General Medicine, Index Medical College Hospital and Research Centre, Indore. Madhya Pradesh, India.
NATH MANJUSHA Department of Pharmacology, Index Medical College Hospital and Research Centre, Indore, Madhya Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2024v17i8.51334

Keywords:

Adverse drug reaction, Pharmacovigilance, Health-care professionals

Abstract

Objectives: The objective of this study was to improve the adverse drug reaction (ADR) reporting rate. This study was undertaken to evaluate the knowledge, attitudes, and practices of the health-care professionals at a tertiary care teaching hospital, regarding ADR monitoring and pharmacovigilance (PV).

Methods: This cross-sectional study was conducted in a tertiary health-care setting of the State Medical College of Uttar Pradesh, health professionals, such as Junior Residents (JRs), Senior Residents (SRs), and consultants were participated in the study. Knowledge, attitudes, the voluntary reporting system, procedures related and reasons for non-reporting of ADRs, etc., with respect to PV was assessed. Informative data were collected and analyzed by applying appropriate software.

Results: Most of the study participants (62.4%) felt that pharmacovigilance report should be made mandatory. The majority of JR knew the theoretical definition and purpose of PVs comparatively more than SR and consultants. Responses showing the attitude of the study participants toward PVs depict that most of the participants (62.4%) felt that PVs report should be made mandatory. Practical aspects of ADRs by different cadres of participant, namely, consultants (68.0%), SR (50%), and JR (35.7%) were found to be statistically significant; p=0.037. The factors discouraging health professionals from reporting ADRs are mainly 1) non-remuneration, 2) difficulty in taking decision, whether ADR has occurred or not or 3 think that single case will not affect ADR database, or 4) lack of time.

Conclusion: Only few of the health professional (20%) were ever reported an ADR but still there is great need to create awareness among the junior/ senior doctors/consultants to improve the reporting of ADRs. An educational intervention and improvement of facilities in coordinating with health-care professionals would definitely bring on a difference in ADRs.

Downloads

Download data is not yet available.

References

Mulchandania R, Kakkarb AK. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions. Int J Risk Saf Med. 2019;30(1):33-44. doi: 10.3233/JRS- 180025, PMID 30175985

World Health Organization. Pharmacovigilance. Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/ pharmvigi/en [Last accessed on 2024 Apr 22].

Sahu S, Rishishwar P, Rathod C. Pharmacovigilance practice for safety of medication system in India. J Phytopharmacol. 2018;7(2):216-21. doi: 10.31254/phyto.2018.7220

National Human Genome Research Institute. Pharmacogenomics FAQ. Available from: https://www.genome.gov/faq/pharmacogenomics [Last accessed on 2024 Apr 22].

Gupte N, Pradhan S. Pharmacovigilance: Perspectives in India. J Med Acad. 2020;3(2):59-62.

Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health professionals’ knowledge, attitudes and practices about pharmacovigilance in India: A systematic review and meta-analysis. PLoS One 2016;11:e0152221. doi: 10.1371/journal.pone.0152221, PMID 27010447

Srinivasan V, Sheela D, Mridula D. Knowledge, attitude, and practice of pharmacovigilance among the healthcare professionals in a tertiary care hospital - A questionnaire study. Biomed Pharmacol J. 2017;10(3):1441-7.

Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors. J Pharm Sci Res. 2011;3(2):1064-9.

Hardeep H, Bajaj JK, Rakesh K. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India. J Clin Diagn Res. 2013;7(1):97-9. doi: 10.7860/JCDR/2012/4883.2680, PMID 23449824

Mohapatra S, Begum MA, Srikanth S, Jamuna Rani R. Knowledge, attitude and the practice (KAP) of pharmacovigilance among health care professionals of a tertiary care teaching hospital of South India. Asian J Pharm Pharmacol. 2019;5(4):669-72. doi: 10.31024/ajpp.2019.5.4.3

Qing L, Su-Min Z, Hua-Ting C, Shi-Ping F, Xin Y, Dong L. The awareness and the attitudes of the healthcare professionals in Wuhan, China about/towards the reporting of adverse drug reactions. Chin Med J (Engl). 2004;117(6):856-61.

Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. An attitudinal survey on the adverse drug reaction reporting by the medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223-6. doi: 10.1111/j.1365-2125.1995.tb04440.x, PMID 7619660

Bateman DN, Sanders GL, Rawlins MD. The attitudes to the adverse drug reaction reporting in the northern region. Br J Clin Pharmacol. 1992;34(5):421-6. PMID 1467137

Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, et al. An educational intervention to improve the physician reporting of the adverse drug reactions (ADRs) in a primary care setting in the complementary and alternative medicine programs. BMC Public Health. 2009;9:274. doi: 10.1186/1471-2458-9-274, PMID 19643033